“…TCR IR therefore serves as a "footprint" of immune status (Calis and Rosenberg, 2014). Emerging studies suggest that TCR IR participates in various liver diseases (including viral hepatitis, liver regeneration, hepatocellular carcinoma, primary sclerosing cholangitis, and alcoholic liver disease) (Chen et al, 2016;Huang et al, 2016;Liaskou et al, 2016;Jiang et al, 2018). In this study, we demonstrate the resetting of intrahepatic TCR IR in response to chronic liver injury, showing an intact characteristic of V, D, J, VJ, and VDJ segment usage and the distribution of CDR3 AA clonotypes during liver fibrosis.…”